Skip to content

QNTM - Quantum Biopharma Ltd. - AlphaYou

Discover Compare Pricing

Sign in Sign up

Home Smart money Buy calls Analyze

Back to stock searchQ

Quantum BioPharma Ltd.

QNTM · NASDAQ

Save to watchlist

Price is syncing

Reported smart-money activity for this stock is still below.

Q

QNTMQuantum BioPharma Ltd.

Overview

No source-backed view yet. This page is available for price, fundamentals, and future receipts as coverage warms.

Key stats

Aug 21

52-wk high: $21.00
52-wk low: $2.07
Prev close: $10.73
Mkt cap: $22.6M
Beta: 0.43
P/S: 91.9x

Smart money

3 funds hold a position.

Real smart money

Funds holding this stock

3 holders

Combined position$62K

CI
Citadel
Ken Griffin · Q2 2026 13F
$57K
position
JC
JPMorgan Chase
Q4 2025 13F

Earnings

Earnings

Results versus expectations

Documents

Quarterly report10-Q Annual report10-K

Financials

Fundamentals

Is the business strong?

This company is running thin margins.

Net margin: 0.0%
Market cap: $23M

Valuation

P/S91.86
P/B35.65

Quality

Operating margin0.0%
ROE

Technicals

Technicals

Price structure

No data yet

Technicals sync when verified market data is available. No sample data is shown.

Company

Symbol: QNTM
Exchange: NASDAQ
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Market cap: $22.63M
Beta: 0.43

Analysts

What do analysts expect?

Analyst target and ratings are on paid plans

See the 12-month consensus target and the buy/hold/sell rating split.

Unlock the full results

Research hubs
About
Editorial policy
Methodology
Source coverage
Corrections

Privacy
Terms
Refunds
Disclaimer

© 2026 AlphaYou. All rights reserved.Not financial advice. Do your own research. Informational data only; past performance does not predict future results.

P/B

35.6x

Profit margin

+0.0%

Op margin

+0.0%

ROE

-621.0%

$4K

position

BO

Bank of America

Q4 2025 13F

$29

position

Coverage gaps for QNTM

No recent insider trade
No recent Congress trade
No recent market-voice mention

The latest quarter is still settling.

A verdict appears once the reported figure is final

Next report

What the street expects next

-621.0%

ROA-51.8%

Growth

Beta0.43